Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kunbu is the Chinese name for a type of edible brown seaweed commonly known as kombu in Japanese. In Traditional Chinese Medicine (TCM), kunbu refers to seaweeds from the genera Saccharina and Ecklonia. It is classified as a "cool herb that transforms phlegm and stops cough." Kunbu is traditionally used to soften hardness, disperse accumulations (such as goiter or nodules), resolve phlegm, clear heat, encourage urination (to reduce edema), and move blood to dispel stasis. Its main indications include goiter (especially due to iodine deficiency), scrofula (lymph node swelling), tumors, liver-spleen enlargement/cirrhosis, edema, hernia, abdominal masses, beriberi, and other swellings or nodules. The mechanism of action in TCM terms involves softening hard masses by dispersing pathological phlegm and reducing congealed blood. Kunbu is salty and cold in nature; it enters the Liver, Stomach, and Kidney meridians according to TCM theory[3][4]. It should not be used by individuals with coldness due to spleen/stomach deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kunbu.